EGFR and breast cancer: Additionally, Ki-67 (proliferation marker), CK 5/6 (cytokeratin marker), EGFR, androgen receptor (AR), and p53 (apoptosis marker) are used as biomarkers to further classify breast cancer using IHC methods.